abstract |
The invention relates to compounds of the general formula IA, IB and IC as described below, comprising pharmaceutically acceptable salts, solvates and hydrates thereof. Compounds and pharmaceutical compositions comprising them according to the present invention can be used in medical conditions involving Ran GTPase. |